Skip to main content

Case Comprehensive Cancer Center

cancer-cells-feat
Existing cancer therapy in narrow use shows significant activity against other cancers
Case Western Reserve University and University Hospitals research team publishes new findings in Nature Cancer A drug used to target IDH1 mutations in select cancers also appears to inhibit the wild-type form of the enzyme, under certain conditions. This feature explains why a large group of…
cancer-cells-feat
Researchers find favorable tradeoffs of PSA screening for prostate cancer
Data support PSA screening, particularly in Black men, for whom there is a shortage of clinical trial evidence Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening…
cancer_cells
6th annual Cancer Disparities Symposium
The 6th annual Cancer Disparities Symposium, hosted by Case Comprehensive Cancer Center, will take place from Thursday, March 3, through Friday, March 4. The symposium will be in a virtual format. "Racism, Poverty and Biology and the Intersection with Cancer Screenings, Diagnosis and Treatment" is…
shave-it-off
Shave It Off!
The St. Baldrick's Foundation head-shaving event has become an annual spring ritual. On March 5, people will shave their heads in solidarity with children who have cancer and typically lose their hair during treatment while raising critical funds for childhood cancer research. At the March 2021…
head-neck-main
Helping cancer patients avoid excessive radiation
Case Western Reserve-led research team identifies biomarker to identify which patients with oropharyngeal cancer will benefit from therapy ‘de-escalation’ A Case Western Reserve University-led team of scientists has used artificial intelligence (AI) to identify which patients with certain head and…
lung-imaging
Artificial intelligence tool predicts treatment response and survival in small cell lung cancer patients
Researchers identify set of patterns from CT scans to help predict patient’s response to chemotherapy Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have used artificial intelligence (AI) to identify patterns on computed…
blanton-tolbert
Blanton Tolbert appointed first associate director for diversity, equity and inclusion for the Case Comprehensive Cancer Center
Blanton S. Tolbert, vice dean for diversity, equity and inclusive excellence for Case Western Reserve School of Medicine, was recently appointed as the first associate director for diversity, equity and inclusion for the Case Comprehensive Cancer Center. The newly created associate director role…
Annual Report to the Nation Part 2: Patient economic burden of cancer care more than $21 billion in the United States in 2019
Part 2 of the latest Annual Report to the Nation on the Status of Cancer finds that cancer patients in the United States shoulder a large amount of cancer care costs. In 2019, the national patient economic burden associated with cancer care was $21.09 billion, made up of patient out-of-pocket costs…
DSC_5627
Campus Spotlight: Great Lakes Breast Cancer Symposium
October is Breast Cancer Awareness Month—an ideal time to join the Case Comprehensive Cancer Center for its annual Great Lakes Breast Cancer Symposium, to be held virtually Oct. 25-26. The event will highlight ongoing basic, translational, clinical and population studies addressing the biological…
lucid-diagnostics-feat-1
Lucid Diagnostics completes $70 million initial public offering
Company’s esophageal cancer prevention tests developed jointly by medical school faculty at Case Western Reserve University and University Hospitals Lucid Diagnostics Inc., a company that produces esophageal cancer tests based on Case Western Reserve University and University Hospitals…